NS5B Inhibitors
5,495 views
Antivirals
- Oseltamivir, Zanamivir
- Acyclovir (Famciclovir, Valacyclovir)
- Ganciclovir
- Foscarnet
- Cidofovir
- NRTIs
- NNRTIs
- Integrase Inhibitors
- Protease Inhibitors
- Entry Inhibitors (Enfuvirtide, Maraviroc)
- NS5A Inhibitors
- NS5B Inhibitors
- NS3/4A Inhibitors
Summary
NS5B inhibitors share a common ending of -buvir, and include drugs such as sofosbuvir and dasabuvir. These drugs inhibit viral RNA-dependant RNA polymerase to prevent viral RNA replication. NS5B inhibitors treat Hepatitis C.
Key Points
- NS5B inhibitors
- Drug Names
- Sofosbuvir
- Nucleoside RNA polymerase inhibitor
- Dasabuvir
- Non-nucleoside RNA polymerase inhibitor
- Sofosbuvir
- Mechanism
- Inhibits viral RNA-dependent RNA polymerase (NS5B)
- Causes RNA chain termination and prevents viral RNA replication
- Requires intracellular activation
- Inhibits viral RNA-dependent RNA polymerase (NS5B)
- Clinical Use
- Hepatitis C virus
- Adverse Effects
- Generally well-tolerated with non-specific side effects
- Fatigue
- Non-specific symptom; seen in 30-60% of patients
- Headache
- Seen in 20-40% of patients
- Drug Names